Shannon Ann Carty (Shannon A Carty)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum Stress

Dendritic Cells

Inflammatory Response

Top Venues

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Tycel Jovelle Phillips, David A Bond, Radhika Takiar, Karson J Kump, Malathi Kandarpa, Philip Boonstra, Tera Lynn Mayer, Victoria R Nachar, Ryan A Wilcox, Shannon Ann Carty, Yasmin H Karimi, Zaneta Nikolovska-Coleska, Mark S Kaminski, Alex F Herrera, Kami Maddocks, Leslie L Popplewell, Alexey V Danilov
Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma. Blood advances (2023)
Hanna S Hong, Nneka E Mbah, Mengrou Shan, Kristen Loesel, Lin Lin, Peter Sajjakulnukit, Luis O Correa, Anthony Andren, Jason Lin, Atsushi Hayashi, Brian R Magnuson, Judy Chen, Zhaoheng Li, Yuying Xie, Li Zhang, Daniel R Goldstein, Shannon Ann Carty, Yu Leo Lei, Anthony W Opipari, Rafael Jose Argüello, Ilona Kryczek, Nobuhiko Kamada, Weiping Zou, Luigi Franchi, Costas Andreas Lyssiotis
OXPHOS promotes apoptotic resistance and cellular persistence in T H 17 cells in the periphery and tumor microenvironment. Science immunology 7 (77) (2022)
Tristan L Lim, David B Lieberman, Adam R Davis, Alison W Loren, Ryan Hausler, Ashkan Bigdeli, Yimei Li, Jacquelyn Powers, Anna Raper, null Regeneron Genetics Center, Shannon Ann Carty, Katherine L Nathanson, Adam Bagg, Elizabeth O Hexner, Kara N Maxwell, Jennifer J D Morrissette, Daria V Babushok
Germline POT1 variants can predispose to myeloid and lymphoid neoplasms. Leukemia (2021)